Author:
Nocini Riccardo,Di Cosola Michele,Cazzolla Angela Pia,Cantore Stefania,Castellaneta Francesca,Covelli Michele
Abstract
BACKGROUND: Chronic rhinosinusitis (CRS) is a common condition that is defined as inflammation of the nose and paranasal sinuses. Nasal irrigation plays an important role in the treatment of CRS. Evidence from basic research favors hypertonic saline over isotonic saline for mucociliary clearance, but evidence from clinical studies is controversial.
AIM: This study aims to investigate the hypothesis that the use of daily nasal irrigation based on sea salt, enriched with natural enzymes and lysozyme, may be useful in patients with CRS.
PATIENT AND METHODS: Patients (30 men and 30 women) 18–55 years old (mean age 41 ± 3 y.o.), with two episodes of acute sinusitis or one episode of chronic sinusitis per year for 2 consecutive years, were enrolled stratified by sex and age and randomly divided into two groups supplementation: Group A (test) and Group B (control/placebo). Moreover, an exit questionnaire was asked to Group A subjects to report whether their sinus-related quality of life has gotten worse, stayed the same, or improved (scale from 0 to ±100%).
RESULTS: The result showed that in the test group (A) from T0 to T1, a reduction of 17.65% for the symptoms related headache and/or facial pressure and a reduction of the 18.18%, for the symptoms relates to congestion and/or nasal discharge. On the other hand, the control group (B) shown less difference between T0 and T1.
CONCLUSIONS: This study strengthens the argument that the tested formulation is a safe, well-tolerated, long-term therapy that patients with chronic sinonasal complaints can and will use at home with minimal training and follow-up.
Publisher
Scientific Foundation SPIROSKI
Reference28 articles.
1. Santacroce L, Charitos IA, Ballini A, Inchingolo F, Luperto P, De Nitto E, et al. The human respiratory system and its microbiome at a glimpse. Biology (Basel). 2020;9(10):E318. https://doi.org/10.3390/biology9100318 PMid:33019595
2. Passali D, Damiani V, Passali GC, Cassano P, Piemonte M, Ciprandi G. The impact of rhinosinusitis in clinical practice: An Italian survey. Acta Biomed. 2020;91(1-S):28-35. https://doi.org/10.23750/abm.v91i1-S.9247 PMid:32073558
3. Tan NC, Psaltis AJ. Latest developments on topical therapies in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2020;28(1):25-30. https://doi.org/10.1097/MOO.0000000000000598 PMid:31789928
4. Woods CM, Lee VS, Hussey DJ, Irandoust S, Ooi EH, Tan LW, et al. Lysozyme expression is increased in the sinus mucosa of patients with chronic rhinosinusitis. Rhinology. 2012;50(2):147-56.
5. Giudice G, Cutrignelli DA, Sportelli P, Limongelli L, Tempesta A, Di Gioia G, et al. Rhinocerebral mucormycosis with orosinusal involvement: Diagnostic and surgical treatment guidelines. Endocr Metab Immune Disord Drug Targets. 2016;16(4):264-9. https://doi.org/10.2174/1871530316666161223145055 PMid:28017141